Long
STML
STML Biotech
• Stem cell therapies
• $7.00 per share in cash
• $250 million in market cap, similar companies are over $800
• $30.00 - $40.00 Upside
• $14.00 Downside
• Stem cell therapies
• $7.00 per share in cash
• $250 million in market cap, similar companies are over $800
• $30.00 - $40.00 Upside
• $14.00 Downside
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.